| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Division of Endocrinology and Metabolism, Department of Medicine, and Department of Psychiatry, Mount Sinai School of Medicine, New York, New York 10029
Address all correspondence and requests for reprints to: Giuseppe Barbesino, M.D., Mount Sinai Medical Center, Box 1055, 1 Gustave L. Levy Place, New York, New York 10128. E-mail: gb{at}doc.mssm.edu
Hashimotos thyroiditis (HT) and Graves disease (GD) are autoimmune thyroid diseases (AITD) in which multiple genetic factors are suspected to play an important role. Until now, only a few minor risk factors for these diseases have been identified. Susceptibility seems to be stronger in women, pointing toward a possible role for genes related to sex steroid action or mechanisms related to genes on the X-chromosome.
We have studied a total of 45 multiplex families, each containing at
least 2 members affected with either GD (55 patients) or HT (72
patients), and used linkage analysis to target as candidate
susceptibility loci genes involved in estrogen activity, such as the
estrogen receptor
and ß and the aromatase genes. We then screened
the entire X-chromosome using a set of polymorphic microsatellite
markers spanning the whole chromosome. We found a region of the
X-chromosome (Xq21.33-22) giving positive logarithm of odds
(LOD) scores and then reanalyzed this area with dense markers in
a multipoint analysis.
Our results excluded linkage to the estrogen receptor
and aromatase
genes when either the patients with GD only, those with HT only, or
those with any AITD were considered as affected. Linkage to the
estrogen receptor ß could not be totally ruled out, partly due to
incomplete mapping information for the gene itself at this time. The
X-chromosome data revealed consistently positive LOD scores (maximum of
1.88 for marker DXS8020 and GD patients) when either definition of
affectedness was considered. Analysis of the family data using a
multipoint analysis with eight closely linked markers generated LOD
scores suggestive of linkage to GD in a chromosomal area (Xq21.33-22)
extending for about 6 cM and encompassing four markers. The maximum LOD
score (2.5) occurred at DXS8020.
In conclusion, we ruled out a major role for estrogen receptor
and
the aromatase genes in the genetic predisposition to AITD. Estrogen
receptor ß remains a candidate locus. We found a locus on Xq21.33-22
linked to GD that may help to explain the female predisposition to GD.
Confirmation of these data in HT may require study of an extended
number of families because of possible heterogeneity.
This article has been cited by other articles:
![]() |
P. INVERNIZZI The X Chromosome in Female-Predominant Autoimmune Diseases Ann. N.Y. Acad. Sci., September 1, 2007; 1110(1): 57 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. YIN, R. LATIF, Y. TOMER, and T. F. DAVIES Thyroid Epigenetics: X Chromosome Inactivation in Patients with Autoimmune Thyroid Disease Ann. N.Y. Acad. Sci., September 1, 2007; 1110(1): 193 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Chen and J. T. Prchal X-linked clonality testing: interpretation and limitations Blood, September 1, 2007; 110(5): 1411 - 1419. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Straub The Complex Role of Estrogens in Inflammation Endocr. Rev., August 1, 2007; 28(5): 521 - 574. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Hsiao, M.-C. Hsieh, K.-J. Tien, S.-C. Hsu, S.-J. Shin, and S.-R. Lin Association between a C/T Polymorphism in Exon 33 of the Thyroglobulin Gene Is Associated with Relapse of Graves' Hyperthyroidism after Antithyroid Withdrawal in Taiwanese J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3197 - 3201. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J Owen, J. A Eden, C. E Jennings, V. Wilson, T. D Cheetham, and S. H S Pearce Genetic association studies of the FOXP3 gene in Graves' disease and autoimmune Addison's disease in the United Kingdom population. J. Mol. Endocrinol., August 1, 2006; 37(1): 97 - 104. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Aliesky, P. N. Pichurin, C.-R. Chen, R. W. Williams, B. Rapoport, and S. M. McLachlan Probing the Genetic Basis for Thyrotropin Receptor Antibodies and Hyperthyroidism in Immunized CXB Recombinant Inbred Mice Endocrinology, June 1, 2006; 147(6): 2789 - 2800. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Invernizzi, M. Miozzo, C. Selmi, L. Persani, P. M. Battezzati, M. Zuin, S. Lucchi, P. L. Meroni, B. Marasini, S. Zeni, et al. X Chromosome Monosomy: A Common Mechanism for Autoimmune Diseases J. Immunol., July 1, 2005; 175(1): 575 - 578. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tomer and T. F. Davies Searching for the Autoimmune Thyroid Disease Susceptibility Genes: From Gene Mapping to Gene Function Endocr. Rev., October 1, 2003; 24(5): 694 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. Kacem, A. Rebai, N. Kaffel, S. Masmoudi, M. Abid, and H. Ayadi PDS Is a New Susceptibility Gene to Autoimmune Thyroid Diseases: Association and Linkage Study J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2274 - 2280. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Adarichev, J. C. Valdez, T. Bardos, A. Finnegan, K. Mikecz, and T. T. Glant Combined Autoimmune Models of Arthritis Reveal Shared and Independent Qualitative (Binary) and Quantitative Trait Loci J. Immunol., March 1, 2003; 170(5): 2283 - 2292. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Vaidya, P. Kendall-Taylor, and S. H. S. Pearce The Genetics of Autoimmune Thyroid Disease J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5385 - 5397. [Full Text] [PDF] |
||||
![]() |
K. Sakai, S. Shirasawa, N. Ishikawa, K. Ito, H. Tamai, K. Kuma, T. Akamizu, M. Tanimura, K. Furugaki, K. Yamamoto, et al. Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto's thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese Hum. Mol. Genet., June 1, 2001; 10(13): 1379 - 1386. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Imrie, B. Vaidya, P. Perros, W. F. Kelly, A. D. Toft, E. T. Young, P. Kendall-Taylor, and S. H. S. Pearce Evidence for a Graves' Disease Susceptibility Locus at Chromosome Xp11 in a United Kingdom Population J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 626 - 630. [Abstract] [Full Text] |
||||
![]() |
Y. Ban, M. Taniyama, and Y. Ban Vitamin D Receptor Gene Polymorphism Is Associated with Graves' Disease in the Japanese Population J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4639 - 4643. [Abstract] [Full Text] |
||||
![]() |
A. P. Weetman Graves' Disease N. Engl. J. Med., October 26, 2000; 343(17): 1236 - 1248. [Full Text] [PDF] |
||||
![]() |
T. Furuya, J. L. Salstrom, S. McCall-Vining, G. W. Cannon, B. Joe, E. F. Remmers, M. M. Griffiths, and R. L. Wilder Genetic dissection of a rat model for rheumatoid arthritis: significant gender influences on autosomal modifier loci Hum. Mol. Genet., September 1, 2000; 9(15): 2241 - 2250. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Hunt, S. E. Marshall, A. P. Weetman, J. I. Bell, J. A. H. Wass, and K. I. Welsh Cytokine Gene Polymorphisms in Autoimmune Thyroid Disease J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1984 - 1988. [Abstract] [Full Text] |
||||
![]() |
R. Nithiyananthan, J. M. Heward, A. Allahabadia, A. H. Barnett, J. A. Franklyn, and S. C. L. Gough A Heterozygous Deletion of the Autoimmune Regulator (AIRE1) Gene, Autoimmune Thyroid Disease, and Type 1 Diabetes: No Evidence for Association J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1320 - 1322. [Abstract] [Full Text] |
||||
![]() |
Mapping the Major Susceptibility Loci for Familial Graves' and Hashimoto's Diseases: Evidence for Genetic Heterogeneity and Gene Interactions J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4656 - 4664. [Abstract] [Full Text] |
||||
![]() |
B. Vaidya, H. Imrie, P. Perros, E. T. Young, W. F. Kelly, D. Carr, D. M. Large, A. D. Toft, M. I. McCarthy, P. Kendall-Taylor, et al. The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus Hum. Mol. Genet., July 1, 1999; 8(7): 1195 - 1199. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Heward, A. Allahabadia, M. Armitage, A. Hattersley, P. M. Dodson, K. Macleod, J. Carr-Smith, J. Daykin, A. Daly, M. C. Sheppard, et al. The Development of Graves' Disease and the CTLA-4 Gene on Chromosome 2q33 J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2398 - 2401. [Abstract] [Full Text] |
||||
![]() |
J. C. Jaume, J. Guo, D. L. Pauls, M. Zakarija, J. M. McKenzie, J. A. Egeland, C. L. Burek, N. R. Rose, W. H. Hoffman, B. Rapoport, et al. Evidence for Genetic Transmission of Thyroid Peroxidase Autoantibody Epitopic "Fingerprints" J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1424 - 1431. [Abstract] [Full Text] |
||||
![]() |
Y. Tomer, G. Barbesino, D. A. Greenberg, E. Concepcion, and T. F. Davies Linkage Analysis of Candidate Genes in Autoimmune Thyroid Disease. III. Detailed Analysis of Chromosome 14 Localizes Graves' Disease-1 (GD-1) Close to Multinodular Goiter-1 (MNG-1) J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4321 - 4327. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |